Home » Topics » Disease categories and therapies » Urology

Urology
RSS

EMEA accepts vardenafil submission for treatment of ED

Feb. 6, 2002

Pharmacia licenses Nastech's nasally administered apomorphine for ED & FSD

Feb. 6, 2002

Curis reports evidence for a unique mechanism for the renal effects of BMP-7

Feb. 6, 2002

Highly effective antinephritic agent derived from linomide

Feb. 1, 2002

Preparation and use of new series of PDE5 inhibitors

Jan. 29, 2002

Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis

Jan. 29, 2002

Vivus cleared to proceed with TA-1790 trial in erectile dysfunction

Jan. 22, 2002

Research snapshots in sexual dysfunction

Jan. 22, 2002

Selective alpha1A-adrenoceptor antagonists claimed for therapy of BPH

Jan. 15, 2002

Ortho-McNeil claims series of PDE5 inhibitors and use in sexual dysfunction

Jan. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...